Introducing the APHRODITE criteria for male infertility diagnosis, prognosis and management
Continuing Medical Education (CME)
19 April 2024
Live Podcast
Infographic
To know more click below:
Overview
Male subfertility/infertility may be idiopathic, congenital or acquired but lifestyle, genetic, and psychological factors, and environmental stressors and pollutants, are implicated in the majority of cases. Clinicians have long recognised the need to improve the assessment and management of male infertility, especially in real-world settings.
Although many cases of male infertility can be corrected through lifestyle or clinical interventions, in the past treatment often centered on the female. As knowledge of spermatogenesis has increased, the potential role of exogenous gonadotropins in the management of selected cases of male infertility has emerged; there is a growing pool of evidence for this approach in humans. It is now essential that the clinician thoroughly investigates and accurately diagnoses the cause of male subfertility/infertility so that the patient’s prognosis is appropriately calculated and communicated. In alignment with this approach, the recent introduction of the APHRODITE criteria for male infertility management aims to improve the diagnosis, classification and management of infertile men.
This workshop and its complementary online activities have been developed by Professor Sandro Esteves, first author of the APHRODITE guideline publication [Esteves, in press 2024]. These guidelines explain recent biological and physiological knowledge relating to spermatogenesis, present the concept of the APHRODITE criteria and describe the application of these criteria in specific case-based scenarios.
Learning Objectives
After participating in both webinars, attendees will be able to:
- ● Characterise the role of gonadotropins in spermatogenesis
- ● Characterise the role of LH in spermatogenesis
- ● Stratify patients with infertility according to the APHRODITE criteria
- ● Based on APHRODITE criteria and guidance, identify potential management strategies for men with the most common causes of male infertility
Target Audience
The program is intended for clinicians, embryologists, andrologists, scientists, and managers working in ART who wish to update their knowledge of advanced techniques and scientific innovations and understand best practices using evidence-based models of care.
Accreditation
“The Introducing the APHRODITE criteria for male infertility diagnosis, prognosis and management, Virtual, Italy 19/04/2024 – 19/04/2024, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME©) with 2.5 European CME credits (ECMEC©s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.”
“Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME© credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME© credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.
“Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME© for ECMEC©s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.”
Chairs
Faculty
International Committee
Baris Ata
Koc University Istanbul
Dubai, United Arab Emirates
Alvaro Ceschin
Brasilia, Brazil
Adriano Fregonesi
Head of the Department of Urology / Andrology State University of Campinas Brazil
Delegate Sociedade Brasileira de Urologia São Paulo (SBU SP)
Partnerships
Association of Reproductive Medicine and Surgery (ARMS)
British Fertility Society (BFS)
International Human Embryology Research Academy (IHERA)
Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number (POSEIDON)
Algerian Society of Reproductive Medicine (SAMERE)
Brazilian Association of Assisted Reproduction (SBRA)
Brazilian Society of Human Reproduction (SBRH)
Brazilian Society of Urology (SBU)
Spanish Fertility Society (SEF)
Italian Society of Gynecology and Obstetrics (SIGO FEDERATION)
Italian Society of Embriology, Reproduction and Research (SIERR)
Portuguese Society of Reproductive Medicine (SPMR)
Scientific Programme
Agenda
From 13.00 to 16.00 Central European Summer Time (CEST)
From 08.00 to 11.00 Brazil Time (BRT)
From 16.30 to 19.30 India Standard Time (IST)
From 21.00 to 00.00 Australian Eastern Standard Time (AEST)
13.00 Med.E.A. Medical Education Academy welcome, introduction, objectives
Sandro Esteves, Brazil; Peter Humaidan, Denmark
SESSION I
Chair: Sandro C. Esteves, Brazil
13.10 Biology of spermatogenesis and pathophysiology of infertility and hypogonadism
Manuela Simoni, Italy
13.30 Q&A: Faculty and Participants
13.40 Introduction to APHRODITE: rationale and group classification
Sandro C. Esteves, Brazil
14.00 Q&A: Faculty and Participants
14.10 Gonadotropin therapy in male infertility management: an overview
Daniele Santi, Italy
14.30 Q&A: Faculty and Participants
SESSION II
Chair: Peter Humaidan, Denmark
14.40 Aphrodite Group 1 with discussion
Leen Antonio, Belgium
14.55 Aphrodite Groups 2 and 3 with discussion
Daniele Santi, Italy
15.10 Aphrodite Groups 3 and 4 with discussion
Sandro Esteves, Brazil
15.25 ART after/during male infertility treatment
Peter Humaidan, Denmark
15.45 Q&A: Faculty and Participants
15.55 Conclusion
Sandro Esteves, Brazil & Peter Humaidan, Denmark